Former Chairman of the Joint Chiefs of Staff U.S. General Peter Pace joins Pathway Genomics Board of Directors

General Peter Pace

San Diego, CA – May 19, 2015Pathway Genomics Corporation, a data-driven global healthcare company and precision medicine clinical laboratory announced today that the sixteenth Chairman of the Joint Chiefs of Staff, retired U.S. Marine General Peter Pace is joining the company’s Board of Directors.

Click to tweet

As Chairman of the Joint Chiefs of Staff, General Pace was the highest-ranking military officer of the U.S. armed forces and served as principal military advisor to the President, National Security Council, Homeland Security Council, and Secretary of Defense.

“General Pace’s experience strategically directing large organizations in both the military and private sector make him an invaluable addition to Pathway Genomics as we grow our existing business and expand into new markets,” said Jim Plante, Pathway Genomics’ Founder and CEO. “We, at Pathway Genomics, are passionate about ensuring our active duty, retired military and the public have access to the best available healthcare. His expertise will help us continue providing innovative products that are disrupting the delivery of healthcare in a positive way today, like our IBM powered mobile healthcare app which is a revolutionary step forward in the field of prevention.”

“I am delighted to join Pathway Genomics as they provide innovative approaches to accessing the best available healthcare globally,” said General Pace. “This is especially important for our nation’s veterans, active duty military, and their families, to ensure that they have access to state-of-the-art, personalized medical information and care. I look forward to working with Pathway Genomics as they develop revolutionary advances in precision medicine, with particular focus on pain management and mental health.”

General Pace is a graduate of the United States Naval Academy. He holds a Master’s Degree in  Administration from George Washington University and attended Harvard University for the Senior Executives in National and International Security program. The General is also a graduate of the Infantry Officers’ Advanced Course at Fort Benning, Ga.; the Marine Corps Command and Staff College, in Quantico, VA; and the National War College, at Ft. McNair, Washington, DC.

About Pathway Genomics Corporation

Since it’s founding in 2008, Pathway Genomics has become known for its dedication to innovation– making it a leader in the commercial healthcare industry. The company’s program with IBM Watson is the first of its kind to merge artificial intelligence and deep learning with precision medicine, providing users with the widest variety of validated and personalized healthcare information delivered to any mobile application.

Based in San Diego, the company’s CLIA and CAP accredited clinical laboratory provides physicians and their patients in more than 40 different countries with actionable and accurate precision healthcare information to improve, or maintain, health and wellness. Pathway Genomics’ testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response for specific medications including those used in pain management and mental health. For more about Pathway Genomics, visit www.pathway.com or follow us on Twitter, LinkedIn and Facebook.

Pathway Genomics Corporation
MEDIA
Jeff Owen, 858-633-6720
pr@pathway.com
or
INVESTORS
Klene Oen
investor@pathway.com